Advertisement

Topics

EC approves AstraZeneca’s Forxiga to treat type-1 diabetes

20:00 EDT 25 Mar 2019 | Pharmaceutical Technology

AstraZeneca has received approval from the European Commission (EC) for the use of Forxiga (dapagliflozin) as an adjunct to insulin...
Read More...

The post EC approves AstraZeneca’s Forxiga to treat type-1 diabetes appeared first on Pharmaceutical Technology.

Original Article: EC approves AstraZeneca’s Forxiga to treat type-1 diabetes

NEXT ARTICLE

More From BioPortfolio on "EC approves AstraZeneca’s Forxiga to treat type-1 diabetes"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...